tailieunhanh - Báo cáo y học: " Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: T Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report | Journal of Medical Case Reports BioMed Central Open Access Case report Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab a case report Neruban Kumaran Dawn A Sim and Adnan Tufail Address Department of Medical Retina Moorfields Eye Hospital London UK Email Neruban Kumaran - neruban@ Dawn A Sim - dawnsim@ Adnan Tufail - Corresponding author Published 28 October 2009 Received 28 October 2009 Journal of Medical Case Reports 2009 3 84 doi 1752-1947-3-84 Accepted 28 October 2009 This article is available from http content 3 1 84 2009 Kumaran et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Myopia has become a big public health problem in certain parts of the world. Sightthreatening complications like choroidal neovascularisation membranes occur in up to 10 of pathological myopia and natural history studies show a trend towards progressive visual loss. There are long-term financial and quality-of-life implications in this group of patients and treatment strategies should aim for long-term preservation of vision. Case presentation A 56-year-old Caucasian woman presented with a best-corrected visual acuity of 6 6-1 in her right eye and 6 24 in her left. Fundal examination revealed pathological myopia in both eyes and an elevated lesion associated with pre-retinal haemorrhage in the left macula. Ocular coherence tomography and fundus fluorescein angiogram confirmed a subfoveal classic choroidal neovascularisation membrane. The patient decided to proceed with intravitreal ranibizumab mg therapy. One month after treatment best-corrected visual acuity improved to 6 12 .